Discovery of novel METTL3 inhibitors: design, synthesis, and in silico and in vitro evaluations
Methyltransferase-like protein 3 (METTL3) is a promising therapeutic target for Acute Myeloid Leukemia (AML). To discover novel METTL3 inhibitors, we designed a series of compounds by hybridizing the natural product Genistein and the non-nucleoside METTL3 inhibitor STM2457. Among the 31 de novo-generated compounds subj...